Ultrasound liver assessment for advanced ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study uses ultrasound to look at how ovarian cancer affects the liver, helping doctors plan surgery better. By taking detailed pictures of the liver before surgery, they hope to improve outcomes for people with advanced or recurrent ovarian cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have suspected or confirmed ovarian, fallopian tube, or primary peritoneal cancer
- Your cancer is advanced (stage III or IV) or has returned after initial treatment
- You are scheduled for surgery to remove visible cancer (complete cytoreductive surgery)
- You haven't had radiation therapy to the liver area before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This study uses advanced computer analysis of CT scans to help doctors plan the best treatment for advanced ovarian cancer. It is designed for patients who are about to start active treatment, such as surgery or chemotherapy.
This study tests whether a special ultrasound using a contrast agent can better tell if an ovarian lesion is benign or malignant. The goal is to help doctors make more accurate decisions without surgery.
This study tests whether a transvaginal ultrasound can be used as a screening tool for ovarian cancer in women at higher risk. It may help find ovarian cancer earlier in people who have a strong family or personal cancer history.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This study uses two types of PET/CT scans (68Ga-FAPI-46 and 18F-FDG) to look for any returning ovarian cancer. The goal is to find recurrence early so you and your doctor can plan the next steps.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.